24/07/2025 08:30
EQS-News: 2G Energy AG recording vibrant order intake growth of 29 % in the second quarter
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: 2G Energy AG / Key words: Incoming Orders br/ 2G Energy AG recording vibrant order intake growth of 29 % in the second quarter br/br/ 24.07.2025 / 08:30... Lire...
24/07/2025 08:15
EQS-News: 2025 Half-Year Results
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Lloyds Banking Group PLC / Key words: Half Year Results br/ 2025 HalfYear Results br/br/ 24.07.2025 / 08:15 CET/CESTbr/ The issuer is solely responsible for the... Lire...
24/07/2025 08:00
Molten Ventures Plc : Transaction in Own Shares
html xmlns=http://www.w3.org/1999/xhtmlbody table border= cellpadding= cellspacing=trtd p Molten Ventures Plc GROW br/ Transaction in Own Shares br/br/span24Jul2025 / 07:00 GMT/BST/spanbr/br//p hr/divdiv p style=margintop:0pt; marginbottom:0pt;... Lire...
24/07/2025 08:00
EQS-News: LPKF increases revenue in the first half of 2025 despite global uncertainties
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: LPKF Laser & Electronics SE / Key words: Half Year Report br/ LPKF increases revenue in the first half of 2025 despite global uncertainties br/br/ 24.07.2025 / 08:00... Lire...
24/07/2025 08:00
vVardis AG : vVARDIS’ Drill-Free Solution Curodont™ Has Treated Over One Million Teeth in 18 Months and Is the Fastest Growing Dental Care Product in Its Category
html xmlns=http://www.w3.org/1999/xhtmlbodytable border=trtd p br/ EQSMedia / 24.07.2025 / 08:00 CET/CESTbr//p divpbvVARDIS’ DrillFree Solution Curodont/bi™/ib Has Treated Over One Million Teeth in 18 Months and Is the Fastest Growing Dental Care Product in Its Category... Lire...
24/07/2025 07:56
ABSCIENCES : AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS
PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO INITIATE THE CONFIRMATORY PHASE 3 STUDY OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS THIS APPROVAL FOLLOWS PROTOCOL VALIDATION BY THE EMA AND FDA AUTHORIZATION Paris, July 24, 2025, 8am CET AB Science SA... Lire...
24/07/2025 07:30
EQS-News: Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: ABIVAX / Key words: Miscellaneous br/ Abivax announces temporary trading halt of its ordinary shares on Euronext Paris br/br/ 24.07.2025 / 07:30 CET/CESTbr/ The... Lire...
24/07/2025 07:30
EQS-News: Vossloh achieves high sales and EBIT growth in the second quarter of 2025
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Vossloh Aktiengesellschaft / Key words: Half Year Report br/ Vossloh achieves high sales and EBIT growth in the second quarter of 2025 br/br/ 24.07.2025 / 07:30... Lire...